Agenda for the 2025 Canadian Cannabis Research Summit
The 2025 Canadian Cannabis Research Summit will bring together the largest assembly of cannabinoid researchers and clinicians in Canada in over a decade. This landmark event will celebrate Canada’s rich diversity of cannabinoid research, shining a spotlight on the research centers, networks, and groups driving innovation in this critical field.
This year, attendees have an exciting opportunity to showcase their research alongside our distinguished invited speakers.
DAY 1 : Wednesday, April 30, 2025 | ||
8:00-9:00 | Breakfast and Registration (outside Northrup Frye Hall, NF003) | |
9:00-9:10 | Welcome and any updates | Hance Clarke, CCIC President/ Ruth Ross, TC3 Director |
SESSION 1: Cannabis and Cannabinoid Research in Canada (Northrup Frye Hall, NF003) | ||
9:10-9:25 | University of British Columbia | Zachary Walsh |
9:25-9:35 | BC Children's Hospital | Rod Rassekh |
9:35-9:45 | Carleton University | Kim Hellemans |
9:45-10:00 | McMaster University | Jason Busse and James McKillop |
10:00-10:10 | University of Saskatchewan | Robert LaPrairie |
10:10-10:25 | University of Manitoba | Lauren Kelly |
10:25-10:35 | Dalhousie University | Sherry Stewart and Candice Crocker |
10:35-10:55 | Group Q&A | |
10:55-11:15 | Health and Coffee Break | |
11:15-11:30 | TC3 | Ruth Ross |
11:30-11:45 | McGill QAQCC/MRCC | Mark Lefsrud |
11:45-12:00 | University of Calgary | Matthew Hill |
12:00-12:15 | University Health Network | Hance Clarke and Karim Ladha |
12:15-12:30 | Western University | Jibran Khokhar, Steven Laviolette, and Daniel Hardy |
12:30-12:40 | Memorial University | Jennifer Donnan |
12:40-12:55 | Universite de Montreal | Patricia Conrod |
12:55-13:05 | University of Alberta | David Collister |
13:05-13:25 | Group Q&A | |
13:25-14:50 | Lunch and Poster Session (Victoria College Alumni Hall and Foyer; Poster session to open at 13:55) | |
SESSION 2: Data Blitz (Northrup Frye Hall, NF003) / C4T Meeting (Northrup Frye Hall, NF007) | ||
14:50-15:05 | Oral delivery of delta-9-tetrahydrocannabinol has pain-modifying effects in mouse models of knee osteoarthritis | Keemo Delos Santos |
15:05-15:20 | High 2-AG potentiates amphetamine-induced dopamine levels; Prolonging dopamine time-course and increasing peak levels. | Catharine Mielnik |
15:20-15:35 | Cannabidiolic acid as a modulator of intracellular lipid transport in the liver of rats with induced MASLD. | Piotr Kurzyna |
15:35-15:50 | Effects of endocannabinoid modulation in an acute mouse model of Parkinson's disease | Lola Zovko |
15:50-16:05 | Health and Coffee Break | |
16:05-16:20 | Can-B cohort: The impacts of cannabis use during pregnancy on circulating endocannabinoids | Aurelie Faucher |
16:20-16:35 | The relationship between the frequency of and motivation for cannabis use with sexual functioning outcomes | Natasha Manuel |
16:35-16:50 | Feasibility and determinants of adherence to wearable technology in substance use disorders | Anna Mouzenian |
17:00-19:00 | Reception at Ned's Cafe | |
19:00 | DAY 1 CLOSES | |
DAY 2: Thursday, May 1, 2025 | ||
8:00-9:00 | Breakfast (outside Northrup Frye Hall, NF003) | |
SESSION 3: Keynote Session (Northrup Frye Hall, NF003) | ||
9:00-9:05 | Day 2 Welcome | Lauren Kelly, CCIC President-Elect |
9:05-9:20 | Prevalence, practices, and attitudes of medicinal cannabis use in pediatrics | Jodi Anderson |
9:20-9:35 | The therapeutic relationship between cannabis use and ADHD: A systematic review | Grace Reynolds |
9:35-10:05 | Update on the Canadian medical cannabis guidelines for chronic pain | Jason Busse |
10:05-10:35 | Cardiometabolic consequences of gestational cannabinoid exposure | Daniel Hardy |
10:35-11:35 | Health and coffee break/Poster session (Victoria College, Alumni Hall and Foyer) | |
11:35-12:05 | Disentangling medicinal and recreational cannabis use among young adults | Jeffrey Wardell |
12:05-12:35 | A 10-year longitudinal study of adolescent cannabis use and mental health outcomes. | Patricia Conrod |
12:35-13:30 | Lunch (Burwash Dining Hall) | |
SESSION 4: Youth and Cannabis (NF003)/ CMCN Meeting (NF007) | ||
13:30-13:45 | Establishing youth risk profiles for driving under the influence of cannabis | Robert Colonna |
13:45-14:00 | High risk, low help: Addressing help-seeking barriers among young men who use cannabis | Madison Hunt |
14:00-14:15 | The effects of extended cannabis abstinence in young adults with co-occurring cannabis use disorder and major depression | Maryam Sorkhou |
14:15-14:30 | Examining the relationship between cannabis usage and mental health among youth and young adults: a qualitative study of youth cannabis consumers and non-consumers | Trinity Vey |
14:30-14:45 | Relationships between cannabis use, brain function and educational attainment in a cohort of 15-16 year old Canadian adolescents | Candice Crocker |
14:45-15:00 | Exploring the relationship between childhood trauma, high-risk cannabis use, and suicidal behaviour among young adults | Isabella Hotston |
15:00-15:15 | Health and Coffee Break | |
15:15-15:30 | Investigating brain signatures of risk and consequences of adolescent cannabis use in a longitudinal cohort | Jeremy Watts |
15:30-15:45 | Divergent outcomes of delta 9 – tetrahydrocannabinol (THC) in adolescence on mesocortical dopamine and cognitive development in male and female mice | Giovanni Hernandez |
15:45-16:00 | Longitudinal examination of the relation of cannabis use to psychotic-like experiences among Australian adolescents: The mediating roles of social and generalized anxiety | Sherry Stewart |
16:00-16:15 | Vaping cannabis and the adolescent brain: Long term impacts on brain and behaviour | Jibran Khokhar |
16:15-16:30 | Varying patterns of cannabis vapor exposure during adolescence have differential neurodevelopmental and behavioral outcomes | Matthew Hill |
16:30-17:00 | Roundtable discussion on the current state of knowledge regarding impacts of cannabis on youth | Led by Matthew Hill and Jibran Khokhar |
17:00 | CONGRESS CLOSES |